FDA-Inspected Site

Neurowave Systems Inc

3 FDA inspections are on record for Neurowave Systems Inc in Beachwood, United States.

Clean· No action indicated

Beachwood, United States · Last updated July 11, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-03-05.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
28 Feb 2025 – 5 Mar 2025Medical Devices & Rad HealthClean
23 Jan 2015 – 3 Feb 2015Medical Devices & Rad Health483View 483 →
4 Apr 2011Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

3 Feb 2015
21 CFR 820.30(f)

Design verification - documentation

Cited by Benjamin J Dastoli

3 Feb 2015
21 CFR 820.30(g)

Design Validation - Risk analysis not performed/inadequate

Cited by Benjamin J Dastoli

3 Feb 2015
21 CFR 820.30(j)

Design history file

Cited by Benjamin J Dastoli

3 Feb 2015
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Benjamin J Dastoli

4 Apr 2011
21 CFR 820.30(g)

Design validation- Lack of or inadequate procedures

Cited by Laureen M Geniusz

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.30(g)Cited across public-safe Form 483 observations2x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.30(j)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Neurowave Systems Inc's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat